Literature DB >> 4879059

Dipyridamole: a controlled trial of its effect in acute myocardial infarction.

A E Gent, C G Brook, T H Foley, T N Miller.   

Abstract

A controlled trial of oral dipyridamole in 103 patients with acute myocardial infarction showed no difference in the number of complications or deaths in either the control or the treated groups. It is concluded that dipyridamole has no benefit in acute myocardial infarction.

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4879059      PMCID： PMC1912602          DOI： 10.1136/bmj.4.5627.366

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  15 in total

1.  PERSANTIN-- A DOUBLE BLIND STUDY.

Authors:  A LEIBERMAN; S GUGLIELMELLI
Journal:  Angiology       Date:  1964-06       Impact factor: 3.619

2.  [Effect of persantin on intercoronary collateral circulation and on survival obtained during progressive coronary occlusion in in animals. Preliminary report].

Authors:  A M VINEBERG; R S CHARI; R PIFARRE; C MERCIER
Journal:  Union Med Can       Date:  1962-10

3.  A LONG-TERM THERAPY OF ISCHEMIC HEART DISEASE.

Authors:  A H GRIEP
Journal:  Angiology       Date:  1963-09       Impact factor: 3.619

4.  The effect of Segontin, Persantin and nitroglycerin on the coronary artery. Experimental studies with cinecoronarography.

Authors:  M DAHL; A KASANEN; T PELTONEN
Journal:  Ann Med Exp Biol Fenn       Date:  1962

5.  Enzymatic deamination and vasodepressor effects of adenosine analogs.

Authors:  D A CLARKE; J DAVOLL; F S PHILIPS; G B BROWN
Journal:  J Pharmacol Exp Ther       Date:  1952-11       Impact factor: 4.030

6.  Dipyridamole in the treatment of angina pectoris. A double-blind evaluation.

Authors:  S Sbar; R C Schlant
Journal:  JAMA       Date:  1967-09-11       Impact factor: 56.272

7.  Effect of dipyridamole on human platelet behaviour.

Authors:  P R Emmons; M J Harrison; A J Honour; J R Mitchell
Journal:  Lancet       Date:  1965-09-25       Impact factor: 79.321

8.  Dipyridamole in long-term treatment of coronary insufficiency.

Authors:  C G Gaddy
Journal:  Va Med Mon (1918)       Date:  1966-06

9.  Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit.

Authors:  P R Emmons; M J Harrison; A J Honour; J R Mitchell
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

10.  Effects of dipyridamole on anastomotic blood flow in experimental myocardial infarction.

Authors:  J R Rees; V J Redding
Journal:  Cardiovasc Res       Date:  1967-04       Impact factor: 10.787
View more
  10 in total

1.  THE PATHOGENESIS OF PULMONARY ARTERIOSCLEROSIS: PROPHYLAXIS WITH DRUGS WHICH AFFECT PLATELET AGGREGATION.

Authors:  Michael Nihill
Journal:  Cardiovasc Dis       Date:  1974

Review 2.  North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-04-25

Review 3.  Platelets, thrombosis and drugs.

Authors:  J F Mustard; M A Packham
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  Antiplatelet agents in coronary disease: are they of prophylactic value?

Authors:  M Verstraete
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

5.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

Review 6.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.

Authors:  Thomas Lenz; Amy Wilson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 8.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

Review 9.  Antiplatelet agents: a review.

Authors:  M L Gantmacher
Journal:  J R Soc Med       Date:  1979-07       Impact factor: 18.000

Review 10.  Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era.

Authors:  Mahmoud Allahham; A Lerman; D Atar; Y Birnbaum
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-10       Impact factor: 3.947
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.